Movement Disorders Flashcards
Levodopa (D2) - PD
- enter via LAT (note: dopamine can’t cross BBB)
- decarboxylated to dopamine; 1-3% enters brain unaltered
- rapidly absorbed from SI (peaks at 1-2 hrs; half life 1-3 hrs)
- “wearing off” phenomenon - long term treatment
Levodopa + Carbidopa (dopa decarboxylase inhibitor)
- decrease peripheral metabolism
- increase plasma levels
- increase half life
- increase levodopa availability to enter brain
- reduced daily requirement for levodopa by 75%
Adverse effects - Levodopa
GI - anorexia, nausea, vomiting (chemo receptor trigger zone in brain stem activated) in 80%
CV - postural hypotension, get HTN with LARGE DOSES (or in combo with MAO inhibitor)
rare - cardiac arrhythmias (inc peripheral catecholamine)
Dyskinesis - choreoathetosis of face + extremities in 80%
Behavior - depression, anxiety, hallucinations, confusion etc.
Antipsychotic drugs (due to adverse effects of levodopa)
- Clozapine
- Olanzepine
- Quetiapine
- Risperidone
“On-off phenomenon” - levodopa
Fluctuation due to:
1. Timing of day (WEARING OFF phenomenon)
2. Unrelated to dose timing (ON-OFF phenomenon)
Severe OFF periods –> APOMORPHINE
Apomorphine
- D2 agonist Rc in caudate/putamen
- give subcutaneously (only one that’s injectable)
- quick/temp relief when experiencing “off” periods
Adverse effect - nausea, sweating, hypotension, drowsiness
If giving Apomorphine, what anti-memetic should you pretreat patient with?
Trimethobenzamide (helps with the adverse effects experienced by Apomorphine)
Levodopa contraindications
- If given with MAO-A inhibitor –> HTN crisis
2. Psychosis, closed-angle glaucoma (OK with open-angle tho), melanoma, peptic ulcer/GI bleed
Bromocriptine
- D2 Rc agonist; alkaloid
- used for endocrine disorders too
- high 1st pass metabolism - CYP 3A4
- 28% bioavailability
Adverse effect - digital vasospasm, peripheral edema, heart arrhythmia; Retroperitoneal fibrosis
Contraindications - peripheral vascular disease
Pramipexole
- D3 Rc agonist
- treats RLS
- 90% excreted unchanged
Ropinirole
- D2 Rc agonist
- treats RLS
- metabolized by CYP 1A2 in liver
Dopamine agonists - Adverse effects/contraindications
GI - constipation, dyspepsia, vomiting, nausea
CV - postural hypotension,
Dyskinesis - similar to levodopa
Mental - hallucinations, confusion, MORE SEVERE than levodopa
Misc. - headache, nasal congestion, pulmonary infiltration, inc arousal
Contraindications - psychosis, MI, peptic ulcer
MAO types
- MAO-A = metabolizes NE + serotonin
- MAO-B = metabolizes phenylethylamine + benzylamine
- MAO-A + MAO-B = dopamine + tryptamine
MAO inhibitors
- Selegiline
2. Rasagiline
Selegiline (deprenyl)
- IRREVERSIBLE
- MAO-B inhibition (MAO-A inhibition at HIGH doses)
- slows dopamine breakdown
Contraindications - meperidine, tricyclic depressants, serotonin reuptake inhibitors (can get serotonin syndrome!!)